プロモーションスケジュール Adhera Therapeutics Inc
詳細なスケジュール
簡易グラフ
会社について
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
| ISIN |
US00687E1091 |
| Industry |
Biotechnology |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
usd |
| Сайт |
https://adherathera.com
|
| Цена ао |
0.0001 |
| 1日あたりの価格変動: |
0% (0.0001) |
| 週ごとの価格変動: |
0% (0.0001) |
| 月ごとの料金変更: |
-98.75% (0.008) |
| 3ヶ月間の価格変動: |
-96.77% (0.0031) |
| 半年間の価格変動: |
-99% (0.01) |
| 年間の価格変動: |
-99.5% (0.02) |
| 3年間の価格推移: |
-99.91% (0.11) |
| 5年間の価格推移: |
-99.93% (0.15) |
| 10年間の価格推移: |
0% (0.0001) |
| 年初からの価格変動: |
0% (0.0001) |
|
|
過小評価
| 名前 |
意味 |
学年 |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| 合計: |
|
2.5 |
|
効率
| 名前 |
意味 |
学年 |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| 合計: |
|
0 |
|
|
|
配当金
| 名前 |
意味 |
学年 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 合計: |
|
0.56 |
|
義務
| 名前 |
意味 |
学年 |
| Debt/EBITDA |
0 |
10 |
| 合計: |
|
10 |
|
成長の衝動
| 名前 |
意味 |
学年 |
| 収益性 Revenue, % |
-96.87 |
0 |
| 収益性 Ebitda, % |
-85.42 |
0 |
| 収益性 EPS, % |
-8.94 |
0 |
| 合計: |
|
0 |
|
| スーパーバイザー |
役職 |
支払い |
生年 |
| Mr. Andrew Albert Kucharchuk M.B.A. |
Vice Chairman, COO, Acting CFO & Chief Business Officer |
|
1981 (44 年) |
